Roth Capital Starts Heat Biologics (HTBX) at Buy
Tweet
Share
E-mailGet Alerts HTBX Hot Sheet
Price: $2.83 --0%
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Roth Capital initiated coverage on Heat Biologics (NASDAQ: HTBX) with a Buy rating and a price target of $2.75.
For an analyst ratings summary and ratings history on Heat Biologics click here. For more ratings news on Heat Biologics click here.
Shares of Heat Biologics closed at $0.60 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts Kanzhun Ltd (2076:HK) at Overweight
- KGI Securities Starts Twilio (TWLO) at Outperform
- Macquarie Starts Sungrow Power Supply Company (300274:CH) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
